国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000028 国药一致

已收盘 12-15 15:00:00

{"stockData":{"symbol":"000028","market":"SZ","secType":"STK","nameCN":"国药一致","latestPrice":24.61,"timestamp":1765782210000,"preClose":24.69,"halted":0,"volume":2284781,"delay":0,"changeRate":-0.0032,"floatShares":478000000,"shares":557000000,"eps":0.9596,"marketStatus":"已收盘","change":-0.08,"latestTime":"12-15 15:00:00","open":24.55,"high":24.68,"low":24.42,"amount":56103200,"amplitude":0.0105,"askPrice":24.61,"askSize":34,"bidPrice":24.6,"bidSize":84,"shortable":0,"etf":0,"ttmEps":0.9596,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"adjPreClose":24.69,"symbolType":"stock","openAndCloseTimeList":[[1765762200000,1765769400000],[1765774800000,1765782000000]],"highLimit":27.16,"lowLimit":22.22,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":556565077,"isCdr":false,"pbRate":0.75,"roa":"--","peRate":25.646103,"roe":"5.29%","epsLYR":1.15,"committee":-0.302041,"marketValue":13697000000,"turnoverRate":0.0048,"status":1,"floatMarketCap":11765000000},"requestUrl":"/m/hq/s/000028/wiki","defaultTab":"wiki","newsList":[{"id":"2591642160","title":"国药一致（000028）披露召开2025年第三次临时股东会通知，12月15日股价下跌0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591642160","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591642160?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:31","pubTimestamp":1765809102,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，国药一致报收于24.61元，较前一交易日下跌0.32%，最新总市值为136.97亿元。该股当日开盘24.55元，最高24.68元，最低24.42元，成交额达5610.32万元，换手率为0.48%。公司近日发布公告称，国药集团一致药业股份有限公司将于2025年12月31日召开2025年第三次临时股东会，会议由董事会召集，现场会议地点为深圳市福田区八卦四路15号一致药业大厦5楼会议室。股权登记日为2025年12月24日，B股股东需在2025年12月19日或之前买入股票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500036107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","BK0082","BK0185","BK0028","BK0175","BK0250","BK0010","000028"],"gpt_icon":0},{"id":"2590502516","title":"国药一致（000028）披露拟清算注销三家子公司，12月12日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590502516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590502516?lang=zh_cn&edition=full","pubTime":"2025-12-12 22:27","pubTimestamp":1765549623,"startTime":"0","endTime":"0","summary":"截至2025年12月12日收盘，国药一致报收于24.69元，较前一交易日下跌1.0%，最新总市值为137.42亿元。该股当日开盘24.94元，最高24.98元，最低24.52元，成交额达1.24亿元，换手率为1.05%。根据近日发布的第十届董事会2025年第八次临时会议决议公告，国药集团一致药业股份有限公司于2025年12月11日以通讯表决方式召开会议，审议通过多项议案。公告指出，上述清算注销事项不会对公司的整体业务经营产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200041868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0188","BK0028","BK0010","BK0185","BK0250","BK0175","BK0082","BK0196"],"gpt_icon":0},{"id":"2590230435","title":"国药一致：披露估值提升计划增进市场认同","url":"https://stock-news.laohu8.com/highlight/detail?id=2590230435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590230435?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:00","pubTimestamp":1765353623,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致12月10日在投资者关系平台上答复投资者关心的问题。请问公司管理层是否关注公司的投资价值，是否认可公司B股股价真实反映了公司质量？公司于11月29日披露了估值提升计划，将围绕稳经营、提质效，做强医药分销及零售主业，提高分红比率，加强与投资者交流，持续提升信息披露质量等方式增进市场认同，努力推动公司价值合理反映上市公司质量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000020201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0185","BK0010","BK0250","BK0028","BK0082","BK0196","000028","BK0188"],"gpt_icon":0},{"id":"2586347733","title":"国药一致（000028）披露估值提升计划，11月28日股价下跌0.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586347733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586347733?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:29","pubTimestamp":1764340193,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘，国药一致报收于24.88元，较前一交易日下跌0.4%，最新总市值为138.47亿元。该股当日开盘25.02元，最高25.05元，最低24.83元，成交额达6124.9万元，换手率为0.51%。近日，国药集团一致药业股份有限公司发布公告称，因股票连续12个月每个交易日收盘价低于最近一个会计年度经审计的每股净资产，公司已触发估值提升计划制定条件。董事会认为该计划有助于提升公司投资价值和增强投资者回报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800040592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","000028","BK0010","BK0185","BK0250","BK0028","BK0082","BK0196"],"gpt_icon":0},{"id":"2586243335","title":"国药一致：国大药房前三季度净利润同比大幅增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2586243335","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586243335?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:45","pubTimestamp":1764233111,"startTime":"0","endTime":"0","summary":"影响药房盈利的核心因素有很多，包括市场环境变化、品类聚焦效果、门店单店产出能力及成本控制水平等等，公司已通过战略性闭店、商品结构优化、统采体系升级等措施提升毛利率，国大药房前三季度净利润同比有较大幅度增长，展现提质增效成果。B股问题的解决需全面统筹考虑，不只取决于个别指标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700022827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"gpt_icon":0},{"id":"2586248600","title":"国药一致：SPD业务处于成长期竞争激烈","url":"https://stock-news.laohu8.com/highlight/detail?id=2586248600","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586248600?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:30","pubTimestamp":1764232253,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致11月27日在投资者关系平台上答复投资者关心的问题。预计带来多少收益？SPD项目由医疗机构招投标确定，目前SPD业务在国内还处于成长期，在医疗机构的渗透处于提升阶段，竞争激烈，以收取服务费为主，公司作为医药分销企业仍为相关医疗机构提供配送服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700021298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0185","BK0010","BK0250","BK0028","BK0082","BK0196","000028","BK0188"],"gpt_icon":0},{"id":"2582806484","title":"股市必读：国药一致（000028）11月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582806484","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582806484?lang=zh_cn&edition=full","pubTime":"2025-11-11 01:22","pubTimestamp":1762795341,"startTime":"0","endTime":"0","summary":"截至2025年11月10日收盘，国药一致报收于25.79元，上涨0.98%，换手率0.87%，成交量4.14万手，成交额1.06亿元。董秘最新回复投资者： 董秘，你好！国药一致器械业务的发展，还会不会继续去拿下更多的SPD业务？后续将持续深化SPD业务布局。交易信息汇总资金流向11月10日主力资金净流出1261.22万元；游资资金净流出220.58万元；散户资金净流入1481.8万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100000559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0175","BK0196","000028","BK0082","BK0028","BK0250","BK0188","BK0010"],"gpt_icon":0},{"id":"2582982374","title":"国药一致：SPD业务持续深化发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2582982374","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582982374?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:27","pubTimestamp":1762763230,"startTime":"0","endTime":"0","summary":"最近这五年，医院供应链延伸项目的医用耗材配送服务项目发展如火如荼，国药一致在广州深圳两地中标运营的项目有什么变化？国药一致器械业务的发展，还会不会继续去拿下更多的SPD业务？公司在SPD业务领域持续深化发展，通过强化中台服务能力和项目统筹管理，供应链增值服务项目数量在两广区域处于领先地位，有效构建标准化、高效率、可复制的服务能力。后续将持续深化SPD业务布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000020567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0188","BK0010","000028","BK0185","BK0175","BK0028","BK0196","BK0082"],"gpt_icon":0},{"id":"2580245848","title":"股市必读：国药一致（000028）11月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2580245848","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580245848?lang=zh_cn&edition=full","pubTime":"2025-11-04 01:13","pubTimestamp":1762189994,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，国药一致报收于25.39元，下跌0.12%，换手率0.69%，成交量3.32万手，成交额8422.64万元。董秘最新回复投资者： 请问贵公司股票长期破净，是否有股票回购计划？当日关注点来自交易信息汇总：11月3日主力资金净流入2079.07万元，占总成交额24.68%，呈现显著主力吸筹迹象。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400000898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0082","BK0250","BK0010","BK0196","000028","BK0185","BK0028","BK0175"],"gpt_icon":0},{"id":"2580264831","title":"国药一致：制定市值管理制度提升信","url":"https://stock-news.laohu8.com/highlight/detail?id=2580264831","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580264831?lang=zh_cn&edition=full","pubTime":"2025-11-03 15:54","pubTimestamp":1762156449,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司股票长期破净，是否有股票回购计划？亦或是有无其他提振股东信心的措施？国药一致回复：感谢您的关注！公司围绕稳经营、提质效，做强医药分销及零售主业，提高分红比率，加强与投资者交流，持续提升信息披露质量等方式增进市场认同，并制定了市值管理制度，努力推动公司价值合理反映上市公司质量。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300017552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0185","BK0082","BK0010","BK0250","BK0175","000028","BK0188"],"gpt_icon":0},{"id":"2580126100","title":"国药一致：结合政策导向服务中老年群体","url":"https://stock-news.laohu8.com/highlight/detail?id=2580126100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580126100?lang=zh_cn&edition=full","pubTime":"2025-11-03 15:54","pubTimestamp":1762156447,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致11月03日在投资者关系平台上答复投资者关心的问题。公司以医药分销及零售为主责主业，其中零售药店是重要的服务提供场景，结合国家的政策导向，为广大中老年群体提供多元化服务；随着市场的变化，我们加大对创新药品，医疗器械类、大健康保健类产品的重视，与国内外厂家合作，将更多更好的产品提供给医疗机构和患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300017542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0082","BK0010","BK0185","BK0028","BK0196","BK0250","000028","BK0188"],"gpt_icon":0},{"id":"2580059614","title":"每周股票复盘：国药一致（000028）Q3净利降9.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580059614","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580059614?lang=zh_cn&edition=full","pubTime":"2025-11-02 10:26","pubTimestamp":1762050371,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，国药一致报收于25.42元，较上周的25.44元下跌0.08%。本周，国药一致10月27日盘中最高价报25.58元。10月31日盘中最低价报25.28元。国药一致当前最新总市值141.48亿元，在医药商业板块市值排名7/32，在两市A股市值排名1353/5163。其中2025年第三季度，公司单季度主营收入183.28亿元，同比下降1.89%；单季度归母净利润2.91亿元，同比下降9.58%；单季度扣非净利润2.8亿元，同比下降10.42%。负债率57.38%，投资收益1.65亿元，财务费用1.2亿元，毛利率10.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0082","BK0188","BK0185","000028","BK0250","BK0175","BK0196","BK0010"],"gpt_icon":0},{"id":"2579140920","title":"图解国药一致三季报：第三季度单季净利润同比下降9.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579140920","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579140920?lang=zh_cn&edition=full","pubTime":"2025-10-30 21:32","pubTimestamp":1761831164,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致2025年三季报显示，前三季度公司主营收入551.24亿元，同比下降2.38%；归母净利润9.57亿元，同比下降10.18%；扣非净利润9.23亿元，同比下降9.87%；其中2025年第三季度，公司单季度主营收入183.28亿元，同比下降1.89%；单季度归母净利润2.91亿元，同比下降9.58%；单季度扣非净利润2.8亿元，同比下降10.42%；负债率57.38%，投资收益1.65亿元，财务费用1.2亿元，毛利率10.49%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000043464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"gpt_icon":0},{"id":"1127818032","title":"国药一致第三季度净利润同比下降9.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127818032","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127818032?lang=zh_cn&edition=full","pubTime":"2025-10-30 18:19","pubTimestamp":1761819587,"startTime":"0","endTime":"0","summary":"10月30日——国药一致（中国国药控股有限公司）第三季度净利润同比下降9.6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","BK0082","BK1197","LU0640798160.USD","LU1115378108.SGD","BK0010","BK0185","BK0028","BK0196","BK0250","000028","BK1500","BK1515","BK0188","01099"],"gpt_icon":0},{"id":"2578507876","title":"每周股票复盘：国药一致（000028）前三季度净利降10.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578507876","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578507876?lang=zh_cn&edition=full","pubTime":"2025-10-26 03:34","pubTimestamp":1761420852,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，国药一致报收于25.44元，较上周的25.16元上涨1.11%。本周，国药一致10月23日盘中最高价报25.74元。本周关注点业绩披露要点：国药一致前三季度归属净利润9.57亿元，同比下降10.18%。公司公告汇总国药一致发布2025年度前三季度业绩快报。2025年第三季度，营业总收入183.28亿元，同比下降1.89%；归属于上市公司股东的净利润2.91亿元，同比下降9.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0175","BK0196","000028","BK0082","BK0028","BK0250","BK0188","BK0010"],"gpt_icon":0},{"id":"2577467328","title":"大摩：相信国药控股未来30天内股价将升 目标价22.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577467328","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577467328?lang=zh_cn&edition=full","pubTime":"2025-10-23 11:19","pubTimestamp":1761189540,"startTime":"0","endTime":"0","summary":"大摩发布研报称，相信国药控股(01099)未来30天内股价将升，发生机率70%至80%，评级“增持”，目标价22.5港元。大摩指，受国内需求疲软及中国技术授权活动影响，药品分销商在2025年持续未受 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251023/c671949699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0028","BK0196","BK0185","BK0082","600511","BK0010","BK0250","000028","BK0175","BK0188","BK0097","BK0012"],"gpt_icon":0},{"id":"2577828713","title":"国药一致（000028）披露2025年度前三季度业绩快报，10月21日股价上涨0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577828713","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577828713?lang=zh_cn&edition=full","pubTime":"2025-10-21 17:23","pubTimestamp":1761038602,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘，国药一致报收于25.34元，较前一交易日上涨0.2%，最新总市值为141.03亿元。该股当日开盘25.32元，最高25.41元，最低25.3元，成交额达5052.26万元，换手率为0.42%。近日，国药一致发布2025年度前三季度业绩快报。2025年第三季度，营业总收入183.28亿元，同比下降1.89%；归属于上市公司股东的净利润2.91亿元，同比下降9.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100026768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0250","BK0188","BK0028","BK0196","BK0010","BK0175","BK0185","000028"],"gpt_icon":0},{"id":"2577426718","title":"国药一致(000028.SZ)前三季度归母净利润9.57亿元，同比下降10.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577426718","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577426718?lang=zh_cn&edition=full","pubTime":"2025-10-21 16:17","pubTimestamp":1761034668,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药一致 披露2025年度前三季度业绩快报，公司实现营业收入551.24亿元，同比下降2.38%;归属于上市公司股东的净利润9.57亿元，同比下降10.18%，相应的基本每股收益同比下降9.95%。2025年1-9月，分销板块实现营业收入405.94亿元，同比下降0.59%;实现净利润7.23亿元，同比下降7.32%。零售板块实现营业收入152.26亿元，同比下降7.14%;实现净利润0.13亿元，同比增长133.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"国药一致(000028.SZ)前三季度归母净利润9.57亿元，同比下降10.18%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000028"],"gpt_icon":0},{"id":"2570010567","title":"股市必读：国药一致（000028）9月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2570010567","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570010567?lang=zh_cn&edition=full","pubTime":"2025-09-26 01:02","pubTimestamp":1758819744,"startTime":"0","endTime":"0","summary":"截至2025年9月25日收盘，国药一致报收于25.16元，下跌0.79%，换手率0.65%，成交量3.1万手，成交额7807.93万元。董秘最新回复投资者： 董秘你好:公司麻精业务表现怎么样？公司下半年业绩估计会增长多少？公司正在加快推进两广地区麻精业务，鼓励区域公司获取相关资质，整合集团体系内相关资源，尽管目前规模占比不大，增速相对较快。当日关注点来自交易信息汇总：9月25日主力资金净流出409.57万元，占总成交额5.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092600000484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0188","BK0010","BK0196","BK0185","BK0175","BK0250","000028","BK0028"],"gpt_icon":0},{"id":"2570069032","title":"国药一致：加快推进两广地区麻精业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2570069032","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570069032?lang=zh_cn&edition=full","pubTime":"2025-09-25 15:45","pubTimestamp":1758786315,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)09月25日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好:公司麻精业务表现怎么样？公司下半年业绩估计会增长多少？国药一致回复：感谢您的关注！公司正在加快推进两广地区麻精业务，鼓励区域公司获取相关资质，整合集团体系内相关资源，尽管目前规模占比不大，增速相对较快。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500019421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0250","BK0188","BK0028","BK0196","BK0010","BK0175","BK0185","000028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765828861634,"stockEarnings":[{"period":"1week","weight":-0.0172},{"period":"1month","weight":-0.0582},{"period":"3month","weight":-0.0472},{"period":"6month","weight":-0.0037},{"period":"1year","weight":-0.1683},{"period":"ytd","weight":-0.1461}],"compareEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":-0.0307},{"period":"3month","weight":0.0016},{"period":"6month","weight":0.1414},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.154}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国药集团一致药业股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"0人","perCapita":"--","listingDate":"1993-08-09","address":"广东省深圳市福田区园岭街道八卦四路15号一致药业大厦","registeredCapital":"55656万元","survey":"　　国药集团一致药业股份有限公司的主营业务是医药分销和医药零售。公司的主要产品是药品、器械耗材、诊断试剂、仪器设备。","listedPrice":3.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药一致,000028,国药一致股票,国药一致股票老虎,国药一致股票老虎国际,国药一致行情,国药一致股票行情,国药一致股价,国药一致股市,国药一致股票价格,国药一致股票交易,国药一致股票购买,国药一致股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}